Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced Malignancies [Phase 1]
Phase 1 study update for DSB2455 assessing safety, tolerability, and activity in advanced HRD-associated cancers, including breast cancer, o…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Sample Collection for Ongoing Research and Product Evaluation Study
Natera reports an ongoing study update focused on sample collection for ongoing research and product evaluation; the trial is currently recr…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study of DM002 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial for DM002 in patients with advanced solid tumors is recruiting, including ovarian cancer, prostate cancer, endometria…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax [Phase 1]
Phase I trial updates the use of Tumor Treating Fields in combination with cabozantinib or with pembrolizumab and nab-paclitaxel for various…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update on the Phase 1/Phase 2 safety and efficacy study of NUV-1511 in adults with advanced solid tumors, including HER2-nega…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating CUSP06 in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors is …
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study of LY4170156 in Participants With Selected Advanced Solid Tumors [Phase 1]
An early-phase study evaluating LY4170156 in selected advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Study of BL0175 Injection in Postmenopausal Female Adults With HR-positive, Locally Advanced or Metastatic Cancer [Phase 1]
A Phase 1 trial of BL0175 Injection in postmenopausal women with HR-positive locally advanced or metastatic breast, ovarian, or endometrial …
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating Raludotatug Deruxtecan (R-DXd) in platinum-resistant, high-grade ovarian cancer, primary peritoneal ca…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Study of SGN-MesoC2 in Advanced Solid Tumors [Phase 1]
Seagen is conducting a Phase 1 study of SGN-MesoC2 in advanced solid tumors, including non-small cell lung cancer, ovarian cancer, pancreati…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors [Phase 1, Phase 2]
A first-in-human Phase 1/2 trial of JAB-8263 in adults with advanced tumors is currently recruiting across multiple cancer types including l…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer [Phase 1]
Phase 1 study evaluating the combination of Niraparib and Dostarlimab (TSR-042) in BRCA-mutated unresectable or metastatic cancers including…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine [Phase 2]
Phase 2 clinical trial assessing intravenous mirvetuximab soravtansine in platinum-resistant, FR-alpha–high expressing advanced high-grade e…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer [Phase 1]
Phase 1 trial evaluating the combination of Cirtuvivint and Olaparib for BRCA/Homologous Recombination Deficiency–related platinum-resistant…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer [NA]
This clinical trial update describes a study comparing multidisciplinary assessment in day hospitalization versus standard care to implement…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer [Phase 2]
This document provides an update on the Phase 2 SMMART-ACT precision medicine trial. It targets patients with advanced breast, ovarian, panc…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer [Phase 1, Phase 2]
TORL Biotherapeutics is conducting a Phase 1/2 trial (CATALINA-4) to evaluate the safety and initial efficacy of TORL-1-23 given with chemot…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas [Phase 1]
DR-0202 is being studied in a Phase 1 trial across multiple locally advanced or metastatic carcinomas; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Surgeons' Ability to Predict Pathological and Molecular Features of Peritoneal Carcinomatosis in Ovarian Cancer
Clinical trial update assessing how accurately surgeons can predict pathological and molecular features of peritoneal carcinomatosis in ovar…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy [NA]
Clinical trial update on prehabilitation care for women with advanced ovarian cancer undergoing neoadjuvant chemotherapy; the study is curre…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
The document describes an ongoing clinical trial that collects peripheral blood or saliva samples for genetic epidemiology studies of famili…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors [Phase 1, Phase 2]
APL-5125 is being studied in a Phase 1/2 trial for adults with advanced solid tumors, with recruitment ongoing across several indications in…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations [NA]
A clinical trial evaluating preventive ovarian cancer surgery in individuals with hereditary gene mutations; the study is active but not rec…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: An Automated Personalized Physical Activity Intervention to Improve Immune Function and Clinical Outcomes in Stage II-IV Ovarian, Primary Peritoneal or Fallopian Tube Cancer and Newly Diagnosed Endometrial Cancer, Life on the Go 3 Study [NA]
Life on the Go 3 is an automated, personalized physical activity program being studied to improve immune function and clinical outcomes in w…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling
This clinical trial update describes the CCANED-CIPHER study, an ongoing investigation using AI-based transcriptomic profiling of platelets …